20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T1789 | Obeticholic Acid | INT-747,6-Ethylchenodeoxycholic acid,6-ECDCA | FXR , Autophagy |
Obeticholic Acid (6-ECDCA) is a Farnesoid X Receptor Agonist. The mechanism of action of obeticholic acid is as a Farnesoid X Receptor Agonist. | |||
T2601 | Vidofludimus | SC12267,4sc-101 | Dehydrogenase , DNA/RNA Synthesis , Interleukin |
Vidofludimus (SC12267) (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH). | |||
T8471 | Vonafexor | EYP001,PLX007,pxl007 | FXR , HBV |
Vonafexor (EYP001) is a farnesoid X receptor (FXR, NR1H4) agonist, with anti-HBV effects | |||
T7886 | Nidufexor | FXR , Autophagy | |
Nidufexor is an agonist for the farnesoid X receptor (FXR). | |||
T2233 | GW 4064 | FXR , Autophagy | |
GW 4064 is an effective farnesoid X receptor (FXR) agonist (EC50 =65 nM). | |||
T11428 | Glyco-Obeticholic acid | FXR | |
Glyco-Obeticholic acid is an active metabolite of Obeticholic acid. Obeticholic acid is an agonist of the farnesoid X receptor (FXR). | |||
T13092 | Tauro-Obeticholic acid | FXR | |
Tauro-Obeticholic acid is an active Obeticholic acid metabolite. Obeticholic acid is an orally bioavailable agonist of farnesoid-X receptor (FXR). | |||
T2015 | Fexaramine | FXR , Autophagy | |
Fexaramine is a small molecule farnesoid X receptor (FXR) agonist with 100-fold increased affinity compared to natural compounds. | |||
T7436 | Cilofexor | FXR , Autophagy | |
Cilofexor inhibits binding of a synthetic peptide, Cilofexor is a farnesoid X receptor (FXR) agonist. | |||
T11426 | Gly-β-MCA | FXR | |
Gly-β-MCA is an orally bioactive, enteroselective and potent inhibitor of the farnesoid X receptor (FXR), a bile acid, used in the study of obesity and diabetes. | |||
T8818 | TC-G 1005 | GPCR19 | |
TC-G 1005 is a potent and selective GPBA agonist (EC50 :0.72 nM; hTGR5). Selective for TGR5 over FXR (farnesoid X receptor). Increases plasma GLP-1 levels and reduces blood glucose in mice. Orally available. | |||
T27316 | Fexarine | ||
Fexarine is a potent, selective agonist of farnesoid X receptor. | |||
T27492 | GSK-8062 | GSK 8062 | |
GSK-8062 is an agonist of farnesoid X receptor (FXR). | |||
T27315 | Fexaramate | ||
Fexaramate is a potent, selective agonist of farnesoid X receptor. | |||
T13093 | Tauro-β-muricholic acid sodium | T-βMCA sodium | FXR |
Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM). | |||
T2968L | Hyodeoxycholic acid sodium salt | Sodium hyodeoxycholate,HDCA sodium | |
Hyodeoxycholic acid sodium salt is a natural secondary bile acid. It improves high-density lipoprotein function, reduces farnesoid X receptor antagonist bile acids, and induces strong cytotoxicity, apoptosis, and IL-8 sy... | |||
T11661 | INT-767 | FXR , GPCR19 | |
INT-767 is a potent farnesoid X receptor (FXR)/TGR5 dual agonist that prevents NASH and promotes visceral adipose brown lipogenesis and mitochondrial function for the study of non-alcoholic steatohepatitis. | |||
T37416 | Tauro-α-muricholic Acid (sodium salt) | ||
Tauro-α-muricholic acid (TαMCA) is an antagonist of the farnesoid X receptor (FXR; IC50 = 28 μM) and a taurine-conjugated form of the murine-specific primary bile acid α-muricholic acid . TαMCA is common in rodents but h... | |||
T75538 | Alismanol M | ||
Alismanol M, a protostane-type triterpenoid isolated from the rhizome of Alisma orientale, functions as a farnesoid X receptor (FXR) agonist with an EC50 value of 50.25 μM. It is utilized in researching cholestasis and n... | |||
T69724 | Cilofexor tromethamine | ||
Cilofexor, also known as GS-9674, is a farnesoid X receptor (FXR) agonist. The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC. In clinical study, cilof... |